U.S. Online Retail and Ecommerce Stock News

NasdaqGS:CGEM
NasdaqGS:CGEMBiotechs

Cullinan Therapeutics (CGEM): Assessing Valuation Following FDA Submission for Zipalertinib Accelerated Approval

Cullinan Therapeutics has started a rolling submission with the FDA for accelerated approval of zipalertinib, its experimental drug for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. This regulatory step follows positive results from the Phase 1/2 REZILIENT1 trial and builds on the drug’s prior Breakthrough Therapy Designation. See our latest analysis for Cullinan Therapeutics. The momentum around Cullinan Therapeutics has turned noticeably positive this month,...
NasdaqCM:OVID
NasdaqCM:OVIDBiotechs

November 2025's Top Penny Stock Opportunities

As the U.S. stock market enjoys a promising streak with major indexes on track for their best week since June, investors are eyeing opportunities across various sectors. Penny stocks, though often seen as a niche area of investment, continue to capture attention due to their potential for growth in smaller or newer companies. While the term may seem outdated, these stocks can still offer intriguing prospects when backed by solid financials and strategic positioning in the current market...
NasdaqGS:VLY
NasdaqGS:VLYBanks

Three Dividend Stocks To Enhance Your Investment Portfolio

As U.S. markets experience a notable upswing, with major indexes on track for their best week since June, investors are keenly observing opportunities to bolster their portfolios amid the positive momentum. In such a dynamic environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to enhance their investment strategies in a thriving market landscape.